237 related articles for article (PubMed ID: 33280156)
1. PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna.
Gradecki SE; Valdes-Rodriguez R; Wick MR; Gru AA
Histopathology; 2021 Jun; 78(7):1000-1008. PubMed ID: 33280156
[TBL] [Abstract][Full Text] [Related]
2. Staged Excision of Lentigo Maligna of the Head and Neck: Assessing Surgical Excision Margins With Melan A, SOX10, and PRAME Immunohistochemistry.
de Wet J; Plessis PJD; Schneider JW
Am J Dermatopathol; 2023 Feb; 45(2):107-112. PubMed ID: 36669074
[TBL] [Abstract][Full Text] [Related]
3. Double Immunohistochemical Labelling of PRAME and Melan A in Slow Mohs Biopsy Margin Assessment of Lentigo Maligna and Lentigo Maligna Melanoma.
Salih R; Ismail F; Orchard GE
Br J Biomed Sci; 2024; 81():12319. PubMed ID: 38566933
[No Abstract] [Full Text] [Related]
4. Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins.
Magro CM; Yang SE; Zippin JH; Zembowicz A
Arch Pathol Lab Med; 2012 Dec; 136(12):1558-64. PubMed ID: 23194049
[TBL] [Abstract][Full Text] [Related]
5. Digital Quantification of Melanocytic Density in Resection Margins of Lentigo Maligna Using SOX10 Versus Hematoxylin-Eosin Staining.
Siarov J; Neittaanmäki N; Mölne J; Gillstedt M; Paoli J
Am J Dermatopathol; 2021 Apr; 43(4):273-277. PubMed ID: 32675472
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining with Melan-A of uninvolved sun-damaged skin shows features characteristic of lentigo maligna.
Bowen AR; Thacker BN; Goldgar DE; Bowen GM
Dermatol Surg; 2011 May; 37(5):657-63. PubMed ID: 21446989
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression of Cancer Testis Antigens on Lentigo Maligna and Lentigo Maligna Melanoma.
Tio D; Willemsen M; Krebbers G; Kasiem FR; Hoekzema R; van Doorn R; Bekkenk MW; Luiten RM
Am J Dermatopathol; 2020 Aug; 42(8):625-627. PubMed ID: 32701706
[TBL] [Abstract][Full Text] [Related]
8. Comparison of MITF and Melan-A Immunohistochemistry During Mohs Surgery for Lentigo Maligna-Type Melanoma In Situ and Lentigo Maligna Melanoma.
Christensen KN; Hochwalt PC; Hocker TL; Roenigk RK; Brewer JD; Baum CL; Otley CC; Arpey CJ
Dermatol Surg; 2016 Feb; 42(2):167-75. PubMed ID: 26771682
[TBL] [Abstract][Full Text] [Related]
9. PRAME Expression in Melanocytic Tumors.
Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the role of routine melan-A immunohistochemistry for exclusion of microinvasion in 120 cases of lentigo maligna.
Suchak R; Hameed OA; Robson A
Am J Dermatopathol; 2014 May; 36(5):387-91. PubMed ID: 24394300
[TBL] [Abstract][Full Text] [Related]
11. Pitfalls in the diagnosis of lentigo maligna and lentigo maligna melanoma, facts and an opinion.
Sina N; Saeed-Kamil Z; Ghazarian D
J Clin Pathol; 2021 Jan; 74(1):7-9. PubMed ID: 33051287
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Handheld Reflectance Confocal Microscopy With Radial Video Mosaicing for Margin Mapping of Lentigo Maligna and Lentigo Maligna Melanoma.
Yélamos O; Cordova M; Blank N; Kose K; Dusza SW; Lee E; Rajadhyaksha M; Nehal KS; Rossi AM
JAMA Dermatol; 2017 Dec; 153(12):1278-1284. PubMed ID: 29049429
[TBL] [Abstract][Full Text] [Related]
13. Soluble adenylyl cyclase antibody (R21) as a diagnostic adjunct in the evaluation of lentigo maligna margins during slow Mohs surgery.
Solky AC; Zembowicz A
Am J Dermatopathol; 2014 Nov; 36(11):882-7. PubMed ID: 24698940
[TBL] [Abstract][Full Text] [Related]
14. Lentigo maligna: review of salient characteristics and management.
Kallini JR; Jain SK; Khachemoune A
Am J Clin Dermatol; 2013 Dec; 14(6):473-80. PubMed ID: 24019181
[TBL] [Abstract][Full Text] [Related]
15. Histologic Features Associated With an Invasive Component in Lentigo Maligna Lesions.
Moreno A; Manrique-Silva E; Virós A; Requena C; Sanmartín O; Traves V; Nagore E
JAMA Dermatol; 2019 Jul; 155(7):782-788. PubMed ID: 31066867
[TBL] [Abstract][Full Text] [Related]
16. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment.
McKenna JK; Florell SR; Goldman GD; Bowen GM
Dermatol Surg; 2006 Apr; 32(4):493-504. PubMed ID: 16681656
[TBL] [Abstract][Full Text] [Related]
17. Unstable solar lentigo: A defined separate entity.
Byrom L; Barksdale S; Weedon D; Muir J
Australas J Dermatol; 2016 Aug; 57(3):229-34. PubMed ID: 26832231
[TBL] [Abstract][Full Text] [Related]
18. Lentigo maligna and malignant melanoma in situ, lentigo maligna type.
Flotte TJ; Mihm MC
Hum Pathol; 1999 May; 30(5):533-6. PubMed ID: 10333223
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of formalin-fixed Mohs surgery and haematoxylin and eosin stains with control contralateral biopsies for lentigo maligna: 5-year follow-up results.
Lawrence CM; Rahim R; Charlton F; Husain A
Br J Dermatol; 2014 Aug; 171(2):298-303. PubMed ID: 24446749
[TBL] [Abstract][Full Text] [Related]
20. Lentigo maligna and lentigo maligna melanoma.
Johr RH; Stolz W
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):512. PubMed ID: 9308580
[No Abstract] [Full Text] [Related]
[Next] [New Search]
